本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rigel Pharmaceuticals

44.48
+0.12000.27%
盤後44.480.00000.00%19:44 EDT
成交量:22.64萬
成交額:1,013.12萬
市值:8.31億
市盈率:2.70
高:45.37
開:44.14
低:43.78
收:44.36
52周最高:52.24
52周最低:24.95
股本:1,867.99萬
流通股本:1,484.66萬
量比:1.03
換手率:1.52%
股息:- -
股息率:- -
每股收益(TTM):16.45
每股收益(LYR):19.48
淨資產收益率:126.90%
總資產收益率:14.95%
市淨率:1.95
市盈率(LYR):2.28

資料載入中...

2020/07/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/15

重要事件披露

8-K - Current report
2020/05/05

重要事件披露

Current report, items 2.02 and 9.01
2020/05/05

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/02/27

重要事件披露

8-K - Current report
2020/02/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 2.02 and 9.01
2019/12/17

重要事件披露

Current report, item 5.02
2019/11/22

重要事件披露

Current report, items 5.02 and 9.01
2019/11/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/20

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/20

持股變動聲明

Statement of changes in beneficial ownership of securities